Aug 13, 2020
Armata Pharmaceuticals Announces Second Quarter 2020 Results and Provides General Corporate Update
Aug 13, 2020
Denver-based Disruptive Tech Company Makes Inc. 5000 Fastest Growing Company List For the 4th Time in a Row
Jun 17, 2020
Armata Pharmaceuticals Announces $15 Million Award from the U.S. Department of Defense (DoD) for Development of Bacteriophage Therapy to Treat S. aureus Bacteremia Infections
Jun 15, 2020
Aridis Pharmaceuticals Appoints Dr. Hasan Jafri as Chief Medical Officer
May 26, 2020
New Publication Reveals Real-World Usage of Vibativ® In Patients With Bacteremia Or Endocarditis
May 04, 2020
Aridis Pharmaceuticals Enrolls Its First COVID-19 Patient in Ongoing Phase 3 AR-301 Clinical Trial in Ventilator Associated Pneumonia (VAP)
Apr 14, 2020
Bausch + Lomb Announces Publication Of 10-Year Armor Study Results On Ocular Antibiotic Resistance In JAMA Ophthalmology
Mar 26, 2020
Study offers potential breakthrough in the war on antibiotic-resistant superbugs
Mar 23, 2020
Cumberland Pharmaceuticals Announces Initiative To Expand Availability Of VIBATIV® To Treat Hospital-Acquired & Ventilator-Associated Pneumonia Resulting From Coronavirus Infections
Mar 04, 2020
Newfound Cell Defense System Features Toxin-Isolating "Sponges"
Feb 05, 2020
San Diego Start-up and UC San Diego Researchers Announce Study Results of Infection Control Technology to Eliminate Stethoscope Pathogen Transmissions
Jan 06, 2020
Novo Holdings REPAIR Impact Fund Invests USD 12 Million in Mutabilis and IBT Vaccines and Provides Strategic Update
Dec 05, 2019
Nozin Nasal Sanitizer Programs Reduce MRSA Infections, Lower Healthcare Costs Say Hospital Clinicians
Nov 25, 2019
New Study Reveals Real-World Usage of Vibativ® In a Variety Of Infections
Nov 12, 2019
EU-Funding: Micreos Awarded EUR2.5 Million for Breakthrough for Skin Problems Including Acne and Eczema
Nov 11, 2019
TenNor Therapeutics Reported Phase II Top-Line Results for TNP-2092
Oct 23, 2019
Biomica to Collaborate With Weizmann Institute of Science to Develop a Selective Treatment Against Antibiotic Resistant Bacteria
Oct 14, 2019
Scientists from NUST MISIS Create a Material for Implants Which Destroys up to 98% of Bacteria
Oct 01, 2019
Luminex Receives FDA 510(k) Clearance for the ARIES® MRSA Assay
Sep 03, 2019
Aridis Pharmaceuticals Reports Phase 2 Clinical Trial Results of AR-105 for the Treatment of Ventilator-Associated Pneumonia Caused by Pseudomonas Aeruginosa